Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation

ACS Nano
Yeh-Hsing LaoKam W Leong

Abstract

Aptamer nanomedicine, including therapeutic aptamers and aptamer nanocomplexes, is beginning to fulfill its potential in both clinical trials and preclinical studies. Especially in oncology, aptamer nanomedicine may perform better than conventional or antibody-based chemotherapeutics due to specificity compared to the former and stability compared to the latter. Many proof-of-concept studies on applying aptamers to drug delivery, gene therapy, and cancer imaging have shown promising efficacy and impressive safety in vivo toward translation. Yet, there remains ample room for improvement and critical barriers to be addressed. In this review, we will first introduce the recent progress in clinical trials of aptamer nanomedicine, followed by a discussion of the barriers at the design and in vivo application stages. We will then highlight recent advances and engineering strategies proposed to tackle these barriers. Aptamer cancer nanomedicine has the potential to address one of the most important healthcare issues of the society.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Nov 12, 1996·Biochemistry·L S GreenN Janjic
Jan 1, 1997·Annual Review of Immunology·M Daëron
Jul 17, 1999·Immunopharmacology·G BieseckerR A Bendele
Oct 9, 2001·The Journal of Biological Chemistry·B J HickeS Warren
Sep 6, 2002·Nature·Christopher P RusconiBruce A Sullenger
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jan 15, 2005·Pharmaceutical Research·Judith M HealyThomas G McCauley
Jan 22, 2005·Annual Review of Medicine·Shahid M NimjeeBruce A Sullenger
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Apr 28, 2005·Biosensors & Bioelectronics·S TombelliM Mascini
Feb 25, 2006·Cell·Shizuo AkiraOsamu Takeuchi
Mar 7, 2006·Nature Reviews. Drug Discovery·Eugene W M NgAnthony P Adamis
Apr 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Omid C FarokhzadRobert Langer
Jun 17, 2006·Cancer Research·Ted C ChuMatthew Levy
Jul 11, 2006·Nature Biotechnology·James O McNamaraPaloma H Giangrande
Jul 18, 2006·Nature Reviews. Microbiology·David H J Bunka, Peter G Stockley
Jul 29, 2006·Proceedings of the National Academy of Sciences of the United States of America·Dihua ShangguanWeihong Tan
Aug 8, 2006·Journal of Thrombosis and Haemostasis : JTH·J E SadlerUNKNOWN Working Party on von Willebrand Disease Classification
Sep 15, 2006·Mayo Clinic Proceedings·Ricardo H AlvarezJorge E Cortes
Oct 13, 2006·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·C S M FerreiraS Missailidis
Nov 14, 2006·Angewandte Chemie·Vaishali BagalkotSangyong Jon
Dec 19, 2006·Molecular Cancer Therapeutics·Christopher R Ireson, Lloyd R Kelland
May 29, 2007·Analytical Chemistry·Zhiwen TangWeihong Tan
Jun 22, 2007·Analytical and Bioanalytical Chemistry·Teresa MairalCiara K O'Sullivan
Jul 13, 2007·Journal of the American Society of Nephrology : JASN·Onkar KulkarniHans-Joachim Anders
Jul 14, 2007·Biomolecular Engineering·Regina StoltenburgBeate Strehlitz
Sep 19, 2007·Molecular & Cellular Proteomics : MCP·Prabodhika MallikaratchyWeihong Tan
Nov 6, 2007·Current Drug Delivery·Abdus SamadM Aqil
Dec 15, 2007·Biochemical and Biophysical Research Communications·Congsheng ChengZhiqing Zhang
Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Frank GuOmid C Farokhzad
Mar 28, 2008·Journal of Proteome Research·Dihua ShangguanWeihong Tan
Jun 14, 2008·The New England Journal of Medicine·Rama D JagerJoan W Miller
Oct 29, 2008·Molecular Systems Biology·Chase L BeiselChristina D Smolke
Nov 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shanta DharStephen J Lippard
Dec 24, 2008·Journal of Medicinal Chemistry·Daqing WangSudhir Agrawal

❮ Previous
Next ❯

Citations

Jul 3, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hongguang Sun, Youli Zu
Sep 22, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Stella Diafa, Marcel Hollenstein
Oct 21, 2015·Biotechnology Advances·Katherine GroffAmy J Clippinger
Dec 15, 2015·ChemMedChem·Pradeepkumar L PatelDavid Sabatino
Feb 24, 2016·ACS Nano·Paula T Hammond
Nov 28, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qinchang ZhuMasaaki Kai
Dec 1, 2015·The Analyst·Hongguang SunYouli Zu
Jan 10, 2016·Nuclear Medicine and Biology·Marlies GijsAndré Luxen
Dec 23, 2015·Scientific Reports·Ken-ichiro MatsunagaIchiro Hirao
Aug 5, 2015·Colloids and Surfaces. B, Biointerfaces·Lu SunChangyang Gong
Oct 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ashim K MitraDhananjay Pal
Mar 16, 2016·Molecular Therapy. Nucleic Acids·Katharina BergUlrich Hahn
Mar 16, 2016·International Journal of Molecular Sciences·Yuanyuan YuGe Zhang
Apr 22, 2016·ACS Applied Materials & Interfaces·Yeh-Hsing LaoLin-Chi Chen
Jun 17, 2016·Molecular BioSystems·Asier GalánMangesh Bhide
Jul 19, 2016·Expert Opinion on Drug Delivery·Noura H Abd Ellah, Sara A Abouelmagd
Dec 14, 2016·Molecular Therapy. Nucleic Acids·Wei-Yun LaiPan-Chyr Yang
Nov 18, 2016·BioImpacts : BI·Saeideh SameYadollah Omidi
Jan 26, 2017·Journal of the American Chemical Society·Liqin ZhangWeihong Tan
Feb 23, 2017·Chemistry : a European Journal·Gonzalo VillaverdeMaría Vallet-Regí
May 5, 2017·Journal of Medicinal Chemistry·Ilaria MonacoMauro Comes Franchini
Nov 17, 2017·International Journal of Molecular Sciences·Pascal RöthlisbergerMarcel Hollenstein
Jul 13, 2018·Chemical Communications : Chem Comm·Yiqiao TianTianfeng Chen
Jul 13, 2018·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Xinxin WangZhike He
Feb 13, 2018·RNA Biology·Jyoti BalaHoshang Unwalla
Nov 28, 2018·Journal of Biomolecular Structure & Dynamics·Weiwen ZhangPinle Li
Apr 9, 2019·Expert Opinion on Emerging Drugs·Eun Ji ParkDong Hee Na
May 23, 2019·The Analyst·Chuanpin ChenTingting Hong
Aug 1, 2019·Current Drug Targets·Jobin JoseBijo Mathew
May 5, 2020·Journal of Biomedical Materials Research. Part a·Somayeh KhezrianMarleny Caceres

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Future Medicinal Chemistry
Roberta E BurdenChristopher J Scott
Journal of Controlled Release : Official Journal of the Controlled Release Society
Andrew S Mikhail, Christine Allen
Annual Review of Biomedical Engineering
John-Michael WillifordHai-Quan Mao
© 2022 Meta ULC. All rights reserved